Walleye Trading LLC - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 277 filers reported holding CRISPR THERAPEUTICS AG in Q2 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.4%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$7,489,350
-30.8%
165,000
-14.5%
0.02%
-37.5%
Q2 2023$10,829,406
-46.8%
192,900
-57.2%
0.03%
-27.3%
Q1 2023$20,367,069
+15.0%
450,300
+3.4%
0.04%
-12.0%
Q4 2022$17,711,205
-41.5%
435,700
-5.9%
0.05%
-45.7%
Q3 2022$30,257,000
+49.7%
463,000
+39.2%
0.09%
+41.5%
Q2 2022$20,206,000
+35.3%
332,500
+39.7%
0.06%
+38.3%
Q1 2022$14,939,000
+173.9%
238,000
+230.6%
0.05%
+161.1%
Q4 2021$5,455,000
-40.0%
71,993
-11.4%
0.02%
-45.5%
Q3 2021$9,098,000
-29.9%
81,282
+1.4%
0.03%
-35.3%
Q2 2021$12,979,000
+63.4%
80,172
+23.0%
0.05%
+45.7%
Q1 2021$7,944,000
+153.2%
65,200
+218.0%
0.04%
+150.0%
Q4 2020$3,138,000
+207.6%
20,500
+68.0%
0.01%
+180.0%
Q3 2020$1,020,000
+7.6%
12,200
-5.4%
0.01%
-16.7%
Q2 2020$948,000
-15.0%
12,900
-51.0%
0.01%
-33.3%
Q1 2020$1,115,000
-82.3%
26,300
-74.5%
0.01%
-79.1%
Q4 2019$6,287,000
+133.8%
103,218
+57.3%
0.04%
+95.5%
Q3 2019$2,689,000
+34.0%
65,615
+54.0%
0.02%
+29.4%
Q2 2019$2,007,000
+260.3%
42,600
+173.1%
0.02%
+240.0%
Q1 2019$557,000
-73.0%
15,600
-78.4%
0.01%
-64.3%
Q4 2018$2,063,000
+1189.4%
72,191
+1905.3%
0.01%
+1300.0%
Q3 2018$160,0003,6000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q2 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,608,874$160,053,562,00054.44%
Abingworth LLP 1,237,202$54,858,00032.62%
NEA Management Company, LLC 2,090,678$92,722,0004.00%
New Leaf Venture Partners, L.L.C. 444,708$19,723,0003.59%
EcoR1 Capital, LLC 500,000$22,175,0002.00%
ARK Investment Management 1,453,590$64,467,0001.95%
CLOUGH CAPITAL PARTNERS L P 337,731$14,978,0001.41%
Casdin Capital, LLC 220,000$9,757,0001.19%
Valiant Capital Management, L.P. 271,700$12,050,0001.07%
Monashee Investment Management LLC 110,000$4,879,0001.03%
View complete list of CRISPR THERAPEUTICS AG shareholders